Chargement en cours...
Lofexidine for acute opioid withdrawal: A clinical case series
INTRODUCTION: Maintaining abstinence through the opioid withdrawal period is a substantial barrier to treatment for patients with opioid use disorder. The alpha-2 agonist lofexidine has demonstrated efficacy and safety in clinical trials, but pragmatic studies describing its use in clinical practice...
Enregistré dans:
| Publié dans: | Ment Health Clin |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
College of Psychiatric & Neurologic Pharmacists
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7534813/ https://ncbi.nlm.nih.gov/pubmed/33062550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2020.09.259 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|